| 1. | Predictors of Study Retention in Drug Abuse Treatment Trials.  |
| | Korte, Jeffrey E. ; Magruder, Kathryn M. ; Sonne, Susan C. ; Sampson, Royce ; Brady, Kathleen T. |
| | Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010. |
| | |
| |
| 2. | Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. |
| | Chen, Hanhui ; Hillhouse, Maureen ; Doraimani, Geetha ; Hasson, Albert ; Ling, Walter |
| | Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010. |
| | |
| |
| 3. | Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy.  |
| | Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie |
| | Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587]. |
| | |
| |
| 4. | Ten Years of Pharmacotherapy Trials in the CTN: An Overview.  |
| | Brady, Kathleen T. |
| | Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010. |
| | |
| |
| 5. | The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment. |
| | Tai, Betty ; Straus, Michele M. ; Liu, David S. ; Sparenborg, Steven ; Jackson, T. Ronald ; McCarty, Dennis |
| | Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13. [doi: 10.1016/j.jsat.2010.01.011]. |
| | |
| |
| 6. | Study Results from the Clinical Trial Network's First 10 Years: Where Do They Lead? |
| | Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M. |
| | Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009]. |
| | |
| |
| 7. | From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. |
| | Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen ; Hasson, Albert ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty |
| | Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009]. |
| | |
| |
| 8. | Multisite Effectiveness Trials of Treatments for Substance Abuse and Co-Occurring Problems: Have We Chosen the Best Designs? |
| | Nunes, Edward V. ; Ball, Samuel A. ; Booth, Robert E. ; Brigham, Gregory S. ; Calsyn, Donald A. ; Carroll, Kathleen M. ; Feaster, Daniel J. ; Hien, Denise A. ; Hubbard, Robert L. ; Ling, Walter ; Petry, Nancy M. ; Rotrosen, John ; Selzer, Jeffrey A. ; Stitzer, Maxine L. ; Tross, Susan ; Wakim, Paul G. ; Winhusen, Theresa M. ; Woody, George E. |
| | Journal of Substance Abuse Treatment 2010;38(suppl 1):S97-S112. [doi: 10.1016/j.jsat.2010.01.012]. |
| | |
| |
| 9. | Buprenorphine Tapering Schedule and Illicit Opioid Use.  |
| | Ling, Walter ; Hillhouse, Maureen ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard |
| | Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x]. |
| | |
| |
| 10. | Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. |
| | Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M. |
| | American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418]. |
| | |
| |
| 11. | Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. |
| | Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron |
| | Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021]. |
| | |
| |
| 12. | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join?  |
| | NIDA Center for the Clinical Trials Network (NIDA CCTN) |
| | |
| | |
| |
